Hologic, Inc. HOLX recently announced the receipt of Health Canada approval for the new Panther Fusion system and Panther Fusion assays for respiratory virus infections. The Panther Fusion respiratory ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Panther Fusion® ...

Hologic’s HOLX fully automated, high-throughput Panther platform remains the foundation of its molecular diagnostics business. The Panther Fusion module, a 2016 addition to the base system, provides ...

Hologic HOLX has highlighted the role of its Panther Fusion platform in supporting the future growth of its Diagnostics business. Fusion is an add-on module to the base Panther system, providing a ...

Hologic Inc. HOLX Breast Health segment is likely to have witnessed strong performance owing to improved semiconductor chip availability and strong backlog. The growing adoption of Panther instruments ...

Hologic Inc. HOLX Breast Health segment is likely to have witnessed strong performance owing to improved semiconductor chip availability. Exceptional demand for clinically differentiated mammography ...

Hologic has won clearance for the Panther Fusion Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. The Marlborough, MA-based company said it has also obtained CE marking in accordance ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, ...

I am initiating a Buy rating on Hologic, Inc. with a fair value of $81, as current risks are priced in. Hologic's strong diagnostic portfolio, recurring consumables revenue, and expanding assay menu ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte ...